PTEN Loss in the Myf5 Lineage Redistributes Body Fat and Reveals Subsets of White Adipocytes that Arise from Myf5 Precursors  by Sanchez-Gurmaches, Joan et al.
Cell Metabolism
ArticlePTEN Loss in the Myf5 Lineage Redistributes
Body Fat and Reveals Subsets of White Adipocytes
that Arise from Myf5 Precursors
Joan Sanchez-Gurmaches,1 Chien-Min Hung,1 Cynthia A. Sparks,1 Yuefeng Tang,1 Huawei Li,1 and David A. Guertin1,*
1Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA
*Correspondence: david.guertin@umassmed.edu
http://dx.doi.org/10.1016/j.cmet.2012.08.003SUMMARY
The developmental origin of adipose tissue and what
controls its distribution is poorly understood. By
lineage tracing and gene expression analysis in
mice, we provide evidence that mesenchymal pre-
cursors expressing Myf5—which are thought to give
rise only to brown adipocytes and skeletal muscle—
alsogive rise to a subset ofwhite adipocytes. Further-
more, individual brown and white fats contain a
mixture of adipocyte progenitor cells derived from
Myf5+ and Myf5neg lineages, the number of which
varies with depot location. Subsets of white adipo-
cytes originating from both Myf5+ and Myf5neg pre-
cursors respond to b3-adrenoreceptor stimulation,
suggesting ‘‘brite’’ adipocytesmayalsohavemultiple
origins. We additionally find that deleting PTEN with
myf5-cre causes lipomatosis and partial lipodystro-
phy by selectively expanding the Myf5+ adipocyte
lineages. Thus, the spectrum of adipocytes arising
from Myf5+ precursors is broader than previously
thought, and differences in PI3K activity between
adipocyte lineages alter body fat distribution.
INTRODUCTION
The obesity epidemic has intensified efforts to understand
adipose tissue biology because obesity is a major risk factor
for type 2 diabetes, dyslipidemias, cardiovascular disease,
cancer, and other conditions (reviewed in Gesta et al., 2007).
Adipose tissue is classified into two types: white adipose tissue
(WAT), the primary site of energy storage, and brown adipose
tissue (BAT), an energy-expending tissue that regulates thermo-
genesis. The amount and distribution of white and brown
adipose can vary considerably between individuals, significantly
impacting the risk for developing metabolic complications
(reviewed in Frontini and Cinti, 2010; Gesta et al., 2007; Tseng
et al., 2010). However, what determines adipose tissue distribu-
tion in mammals is poorly understood.
It is becoming clear that different WAT depots are heteroge-
neous. For instance, in mammals individual WAT depots appear
at different times in development and have unique functional
characteristics (reviewed in Billon and Dani, 2012; Cristancho348 Cell Metabolism 16, 348–362, September 5, 2012 ª2012 Elsevieand Lazar, 2011; Gesta et al., 2007). Moreover, obesity charac-
terized by increased visceral fat associates with high risk of
metabolic disease, while the risk associated with increased
subcutaneous fat is low. The distinction between subcutaneous
and visceral fat may be oversimplified, because evidence exists
suggesting that metabolic properties also vary between some
visceral fat depots (Edens et al., 1993; Fried et al., 1993; Tchko-
nia et al., 2005). Studies in mice and with human adipose tissue
further indicate that individual adipocytes within a depot have
different gene expression signatures and growth characteristics,
indicating heterogeneity even exists within a single fat depot
(Blu¨her et al., 2002; de Souza et al., 2001; Fortier et al., 2005;
Jerna˚s et al., 2006). These findings have led to a hypothesis
that individual white adipocytes have different developmental
origins. However, distinct white adipose tissue lineages have
not been clearly identified.
Mounting evidence indicates that BAT exists in variable
amounts in adult humans and positively influences human
metabolism (Cypess et al., 2009; van Marken Lichtenbelt et al.,
2009; Virtanen et al., 2009; Enerba¨ck, 2010; Nedergaard and
Cannon, 2010) and that therapeutically increasing brown fat
energy expenditure could treat obesity (reviewed in Tseng
et al., 2010). To this end, increasing attention is being given to
brown adipose-like cells that can be induced to formwithin white
fat by b3-adrenergic receptor stimulation. These ‘‘brite’’ (brown
in white) or ‘‘recruitable’’ brown adipocytes may potentially be
targets for antiobesity therapies aimed at increasing cellular
bioenergetics (reviewed in Gesta et al., 2007; Tseng et al., 2010).
One emerging view is that brown fat is developmentally more
similar to skeletal muscle than to white fat (reviewed in Tseng
et al., 2010). For example, gene expression analysis indicates
that primary brown but not white preadipocytes exhibit
a myogenic-like transcriptional profile (Timmons et al., 2007).
In vivo fate mapping experiments further suggest that brown
fat originates from a mesenchymal precursor cell that expresses
the myogenic transcription factor Myf5 (Atit et al., 2006; Seale
et al., 2008). This has led to a widely accepted model in which
brown fat and skeletal muscle share a common Myf5+ precursor
cell—explaining the favorable metabolic properties of brown
fat—and that an undefined Myf5neg precursor gives rise to white
fat and to the inducible brite adipocytes (reviewed in Cristancho
and Lazar, 2011; Enerba¨ck, 2009; Tseng et al., 2010). Recent
progress has beenmade in identifying populations of cells within
adipose tissues that contain adipocyte progenitor cells (APCs)
(Rodeheffer et al., 2008; Tang et al., 2008). To what extent the
Myf5+ lineage contributes to the BAT APC pool and the identityr Inc.
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cytes are unclear.
The signals that regulate brown fat differentiation are poorly
defined. In vitro, preadipocyte differentiation assays are supple-
mented with insulin, which activates the phosphatidylinositol
3-kinase (PI3K) signaling pathway and stimulates adipogenesis
(reviewed in Cannon and Nedergaard, 2004; Rosen and
MacDougald, 2006). PI3K activity is negatively regulated by
PTEN (phosphatase and tensin homolog). In this study, we
genetically activated PI3K signaling (by conditionally deleting
PTEN) specifically in the Myf5+ lineage to begin investigating
how nutrient and growth factor sensing pathways regulate
brown fat development in vivo. Strikingly, losing PTEN in the
Myf5+ lineage alters whole body adipose tissue distribution,
resulting in combined lipomatosis and partial lipodystrophy.
Unexpectedly, this results from the expansion of a subset
of white and brown adipocytes that arise from Myf5-Cre+
precursors. Lineage tracing analysis further reveals that each
fat depot contains adipocyte progenitor cells arising from
Myf5+ precursors, the number of which varies depending upon
depot location. Our results suggest that the spectrum of
adipocytes originating from Myf5+ precursors is broader than
previously thought and that activating PI3K in Myf5+ precursors
redistributes body fat by selectively expanding the Myf5+ adipo-
cyte lineages.
RESULTS
Deleting PTEN in Myf5+ Precursors Causes Combined
Lipomatosis and Partial Lipodystrophy
To better understand the signaling mechanisms controlling
brown fat development in vivo, we activated the PI3K signaling
pathway in brown fat precursors by crossing PTENfl/fl mice to
the myf5-cre knockin line (Seale et al., 2008; Tallquist et al.,
2000). Immediately from birth the myf5-cre;ptenfl/fl conditional
knockout (PTENmyf5cKO) mice are distinguishable from their
littermates by a horse collar-like growth and torpedo shape
(Figures 1A and 1B). Fewer than expected PTENmyf5cKO mice
survive to weaning (25% expected; 15% actual), although
mutant embryos are present in late development at the expected
frequency, indicating that some PTENmyf5cKO mice die during or
shortly after birth (Table S1). PTENmyf5cKO mice die sporadically
with a maximum life span of around 6 months (Figure S1A). At
6–12 weeks of age, PTENmyf5cKO mutants show no significant
differences in total weight (Figure S1B); however, they have
slightly increased fat mass (Figure S1C).
Despite their overall normal weight, individual tissue mass
analysis indicates that the PTENmyf5cKO mutants have a severe
adipose tissue distribution disorder. Most striking is their greatly
enlarged interscapular, subscapular, and cervical brown fat
(iBAT, sBAT, and cBAT), interscapular WAT (iWAT), retroperito-
neal WAT (rWAT), and vertebral WAT depots (Figures 1C–1F
and S1D–S1E). The mutant iBAT and iWAT show the greatest
growth differential, increasing to a tissue to body weight ratio
that is 4.7 and 3.4 times larger than litter-matched control
tissues by 6 weeks of age (Figures 1D and 1F). The oversized
BAT is readily apparent in neonates, when its function is
critical for thermogenesis, while the oversized WATs rapidly
grow within a few weeks of birth (not shown). Remarkably, otherCell MeWAT depots such as the mesenteric, perigonadal (pgWAT),
inguinal (ingWAT), gluteal, and posterior subcutaneous WATs
are absent (Figures 1G, 1H, and S1F). In contrast, the limb
skeletal muscles (e.g., gastrocnemius, quadriceps, and triceps)
are reduced in mass, as are several other lean tissues including
the heart, liver, kidney, lung, testes, and brain (Figure S1G). Thus,
PTENmyf5cKO mice cannot regulate adipose tissue distribution
and develop severe combined lipomatosis, lipoatrophy, and
lean tissue wasting.
Adipose Tissues in PTENmyf5cKO Mice Have Larger
Adipocytes and More Cells
Hematoxylin and eosin (H&E) staining indicates that the
PTENmyf5cKOBAT lipid dropletsmaintain their typical multilocular
appearance; however, the mutant tissues have visibly larger lipid
droplets and fewer nuclei per mm2 (Figures 2A, 2B, S2A, and
S2B), indicating individual mutant brown adipocytes are larger.
Similar to the mutant BATs, the unilocular lipid droplets charac-
teristic of white adipocytes are also larger in the PTENmyf5cKO
rWAT and iWAT depots (Figure 2A). The average lipid droplet
diameter in the mutant WATs is nearly twice the diameter of lipid
droplets in control white adipocytes (Figures 2C and S2C–S2E),
indicating that the increased size of PTENmyf5cKO fat depots is
caused in part by hypertrophy. In contrast to the PTENmyf5cKO
fats, the size of individual skeletal muscle fibers is decreased
(Figures 2A, S2A, S2F, and S2G).
Brown adipose precursor cell pools are easily visible by H&E
staining of sectioned embryos. Deleting PTEN with myf5-cre
increases the size of brown fat precursor cell pools in
PTENmyf5cKO E14.5 embryos, consistent with a role for PTEN in
regulating precursor cell number (Figure 2D) (reviewed in Hill
andWu, 2009). At high magnification E14.5 PTENmyf5cKO precur-
sors appear qualitatively more similar to controls, but by E17.5
they prematurely begin accumulating lipid (Figure 2E), sug-
gesting aberrant lipid accumulation is secondary to a primary
defect in cell number regulation. By 6 weeks of age the mutant
iBAT contains 3.5-fold more total genomic DNA compared to
control tissues, indicating that the total cell number of the
developed mutant brown fats is also increased (Figure 2F).
Similarly, 6 week mutant rWAT contains more total genomic
DNA (a 3.6-fold increase over control) (Figure 2G). Notably, the
total DNA content of both depots between 6 and 12 weeks of
age minimally changes, indicating that the difference in total
cell number between control and mutant fats may result in part
from the expansion of embryonic/neonatal progenitor cells.
PTENmyf5cKO Mice Completely Lack PTEN in Both
the White and Brown Fats
Immunohistochemical analysis reveals robust PTEN loss and
strong PI3K pathway activation (by increased AKTS473 phos-
phorylation) in the embryonic brown fat precursor cell pools
(Figure 3A), indicating that myf5-cre deletes PTENfl/fl early in
brown fat development and in most brown fat precursors.
Immunoblotting of tissue lysates prepared from 6-week-old
PTENmyf5cKO mice reveals robust PTEN ablation and AKT acti-
vation in the adult iBAT, sBAT, and cBAT depots (Figures 3B
and S3A), further validating that myf5-cre targets PTENfl/fl
deletion to the brown fat lineage. The myf5-cre also efficiently
deletes PTEN in primary BAT preadipocytes, which we purifiedtabolism 16, 348–362, September 5, 2012 ª2012 Elsevier Inc. 349
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in vivo findings, PTEN-deficient BAT preadipocytes proliferate
faster than control preadipocytes in culture (Figure 3C), and
when induced to differentiate prematurely accumulate lipid
(Figure 3D).
Interestingly, we are unable to detect significant loss of PTEN
in the limb muscles by immunoblot (Figures 3B and S3A),
despite detecting recombination at the PTENfl/fl locus by PCR
(not shown), and tracing the Myf5 lineage to all limb skeletal
muscle fibers (Figures 4A, 4E, and S3D). We noted evidence in
the literature suggesting that redundant Myf5+ and Myf5neg
lineages converge to generate skeletal muscles (Gensch et al.,
2008; Haldar et al., 2008). In fact, one report elegantly demon-
strates that a greater fraction of Myf5+ precursors contributes
to the epaxial lineages (e.g., vertebrae, rib, back, and neck
muscles) compared to the hypaxial lineages (e.g., diaphragm,
abdominal muscles, and limb muscles) (Haldar et al., 2008).
Therefore, we reasoned that myf5-cre might inefficiently delete
PTEN in the myotubes of limb muscles because a Myf5neg
myoblast (expressing PTEN) fusing to a Myf5+ myoblast (deleted
for PTEN) could partially compensate for the PTEN deficiency. If
this is true, then one might expect PTEN loss to be more readily
detectable in the neck musculature, which arises from a greater
contribution of Myf5+ precursors compared to the limb muscu-
lature. This is indeed the case for the PTENmyf5cKO trapezius
muscle, in which partial loss of PTEN and increased AKT
phosphorylation is detectable by immunoblotting (Figure 3B).
Although PTEN protein levels are unchanged in limb muscles,
PTEN mRNA levels are reduced (Figure 3E), suggesting that
the limb muscles can also regulate PTEN expression posttrans-
lation (Wang and Jiang, 2008). Regardless, we conclude that in
the PTENmyf5cKOmice, a systemic effect rather than intrinsic loss
of PTEN causes the decrease in limb muscle fiber size and total
mass.
White fat is not predicted to arise from a Myf5+ precursor;
therefore, the dramatic WAT phenotype of PTENmyf5cKO mice is
unexpected. Surprisingly, immunoblotting reveals that myf5-
cre robustly deletes PTENfl/fl in iWAT and rWAT to the same
extent as it does in mutant BAT (Figure 3B). Moreover, recombi-
nation at the PTEN locus is detected by PCR in the mutant
WAT (not shown), and PTEN mRNA expression is decreased in
the mutant iWAT and rWAT to the same extent as it is in mutant
iBAT (Figure 3E). This contradicts the hypothesis that brown
adipose is the only fat that arises from Myf5+ precursors and
suggests some white adipocytes are also derived from a Myf5+
expressing progenitor cell.Figure 1. Deleting PTEN in the Myf5+ Lineage Causes Severe Combine
(A) Anatomy of a 6-week-old PTENmyf5cKO mutant (right) and a littermate contro
shape.
(B) Lateral view of a PTENmyf5cKO mouse (bottom panel) and a control (top panel
(C) Macroscopic images of control and PTENmyf5cKO mouse. Black arrow indicate
WAT (top panels). Vertebral WAT is indicated with a black dashed circle. A star i
(D) Macroscopic images of iBAT (scale bar = 5 mm)
(E) Macroscopic images of rWAT (black arrow).
(F) Fat mass relative to body weight (top panel) and total fat mass (bottom pan
controls (white bars) (n = 13; bars represent mean ± SEM; t test; ***p < 0.001).
(G) Representative images of mesenteric fat in control (left panels) and PTENmyf5
(H) Representative images of perigonal WAT (black arrow). See also Figure S1.
Cell MeA Subset of White Adipocytes Arises from Myf5+
Precursors
To explore the possibility that some white adipocytes arise from
Myf5+ precursors, we generated myf5-cre;R26R-EYFP mice
(which express YFP only in cells that have previously expressed
the myf5-cre knockin allele) to trace the Myf5+ lineage. As
expected, the myf5-cre;R26R-EYFP mice express high levels
of YFP mRNA in the iBAT, sBAT, and cBAT and in skeletal
muscles (triceps, quadriceps, gastrocnemius, and trapezius),
but not in the heart, liver, spleen, or kidney (Figure 4A), which
is consistent with brown fat and skeletal muscle arising from
aMyf5+ precursor (Seale et al., 2008). Moreover, YFP expression
is also low in both ingWAT and pgWAT. However, myf5-cre;
R26R-EYFP mice express 15–20 times more YFP mRNA in the
iWAT and rWAT compared to ingWAT and pgWAT, and at levels
comparable to YFP expression in BAT. Notably, YFP mRNA
expression in iWAT and rWAT does not correlate with ucp1 or
prdm16 mRNA expression (brown fat markers) (Figures 4A–
4C). For example, ucp1 and prdm16 express more highly
in ingWAT (Figures 4B and 4C), which has low YFP expression
(Figure 4A). Thus, myf5-cre lineage tracing labels iWAT and
rWAT in addition to BAT and skeletal muscle.
We also generated myf5-cre;R26R-LacZ mice to confirm
by an alternate approach that iWAT and rWAT trace to the
Myf5+ lineage. Consistent with YFP mRNA expression, myf5-
cre;R26R-LacZ mice strongly express LacZ in whole BAT
(Figure 4D). Similarly, the rWAT and iWAT depots strongly stain
LacZ positive. In contrast, the pgWAT and ingWAT faintly stain
positive, while liver stains negative. Upon sectioning, strong
LacZ expression is visible in nearly all iBAT and sBAT adipo-
cytes, while many unilocular adipocytes in rWAT and iWAT
also stain positive (Figures 4E and S3C). Although difficult to
find, a few LacZ-positive cells are detectable in the pgWAT
and to a lesser extent in the ingWAT; however, the adipocytes
in these depots are predominantly LacZ negative (Figures 4E
and S3C). Notably, many adipocytes within ingWAT contain
multilocular lipid droplets indicative of inducible brown fat cells
(also called brite fat) (Figure 4E), which are thought to arise
from a Myf5neg lineage (Seale et al., 2008). Consistent with this
notion, none of these cells are LacZ positive.
We next profiled the gene expression pattern of iBAT and
rWAT with well-established brown and white fat markers to ask
if the WAT tracing to the Myf5+ lineage has a BAT signature
(Schulz et al., 2011; Seale et al., 2008; Walde´n et al., 2012). By
quantitative RT-PCR, we find as expected that whole iBAT
more highly expresses the brown fat markers cidea, prdm16,d Lipomatosis and Partial Lipodystrophy
l (left). PTENmyf5cKO mice have a horse-collar-like growth and overall torpedo
).
s iBAT region; white arrow indicates iWAT. White dashed circles show axillary
ndicates the trapezius muscle.
el) for the indicated tissues in 6-week-old PTENmyf5cKO mice (black bars) and
cKO mouse (right panels).
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Figure 2. PTEN-Deficient Fats Have Large Adipocytes and More Total Cells
(A) H&E images of iBAT, iWAT, rWAT, and quadriceps from a control and PTENmyf5cKO mouse (403).
(B) Nuclei density per mm2 of iBAT, sBAT, and cBAT (n = 5, 6 weeks old).
(C) rWAT adipocytes cell diameter from 6-week-old mice (n = 7).
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PTEN positive). Moreover, rWAT more highly expresses the
white fat markers HoxC8, HoxC9, and Dpt compared to iBAT
(Figure 4G), indicating that despite its strong labeling with
myf5-cre, rWAT does not have a brown fat signature. These
data suggest that Myf5+ precursors give rise to a subset of white
adipocytes in addition to brown adipocytes.
The Number of Adipocyte Progenitor Cells Arising from
Myf5+ Precursors Varies with Depot Location
To more closely examine the Myf5-lineage contribution to each
adipose tissue depot, we isolated individual depots from myf5-
cre;R26R-LacZ mice, prepared their stromal vascular fractions
(SVF), and examined cellular LacZ expression. Compared
to cre-lacking R26R-LacZ controls, the plated SVF of myf5-
cre;R26R-LacZ iBAT, iWAT, and rWAT strongly stain positive
for LacZ (Figure 5A). The iBAT SVF contains the highest
percentage of LacZ-positive cells at 86.2%, while 62.5% and
74.4%, respectively, of the iWAT and rWAT SVF cells label
LacZ positive (Figure 5B). In contrast, only 11.9% of the ingWAT
and 13.3% of the pgWAT SVF cells are LacZ positive. Neverthe-
less, the SVF of each depot contains cells originating from
a Myf5+ precursor.
To determine the adipogenic potential of the LacZ-positive
SVF cell populations, we differentiated the SVF cells purified
from myf5-cre;R26R-LacZ mice and stained them for LacZ
expression (Figure S4A). Of the lipid-containing cells in the
differentiated fractions, 99.4% of the iBAT-derived cells are
LacZ positive (Figure 5C), indicating the adipogenic cells isolated
from BAT are predominantly of Myf5+ precursor origin. In iWAT
and rWAT, LacZ labels 48.2% and 58.1% of the lipid-containing
cells, respectively, indicating that nearly half of the adipogenic
cells in the SVFs of these depots also originate from a Myf5+
precursor. In contrast, only a few (<2%) of the lipid-containing
cells in the ingWAT and pgWAT differentiated fractions are LacZ
positive. In these depots, it appears that the majority of Myf5+
lineage SVF cells are nonadipogenic under these conditions.
The SVF contains blood, vascular, nerve, and matrix cells in
addition to adipocyte progenitor cells (APCs). To specifically
examine the Myf5-lineage contribution to the APC population
in each depot, we generated myf5-cre;R26R-EYFP mice, puri-
fied the APCs from each depot and quantified how many of
them express YFP by flow cytometry. We first separated the
adipocyte pools from the SVF in each depot and examined
YFP expression using coexpression of leptin and pref1, respec-
tively, to monitor fraction purity (Figures S4C and S4D). Con-
sistent with the LacZ lineage-tracing analysis, YFP expresses
highly in both the adipocyte fraction and SVF of iBAT, sBAT,
iWAT, and rWAT (Figures S4C and S4D). The APCs are con-
tained within a CD31:CD45:Ter119:CD29+:CD34+:Sca1+
cell population (Rodeheffer et al., 2008). Approximately 85% of
the APCs purified from the iBAT or sBAT SVFs express YFP
protein (Figure 5G), consistent with brown fat progenitor cells(D) Images of H&E-stained E14.5 control and PTENmyf5cKO embryo sections (103)
and cBAT (3) precursor pools are enlarged.
(E) Detail of embryonic BAT precursors at E14.5 and E17.5. Lipid droplets can b
(F) Total genomic DNA-purified iBAT in 6- and 12-week-old control (white bars) a
(G) Total genomic DNA from rWAT (n = 8). Bars represent mean ± SEM; t test; *p
Cell Mebeing largely derived from Myf5+ precursors. In the iWAT and
rWAT, 48.9% and 69.4% of the APCs, respectively, are also
YFP positive, correlating well with the percentage of LacZ-
positive adipogenic cells in their SVFs (compare to Figure 5C).
Also consistent with the LacZ lineage tracing, most APCs puri-
fied from ingWAT or pgWAT are YFPneg, although a small number
of APCs in each depot (6.1% and 9.1%, respectively) do express
YFP (Figure 5G). This also correlates with the LacZ tracing in
their SVFs (Figure 5B). However, only 1.6% and 0.6% of the
Myf5 lineage SVF cells in these depots are adipogenic in vitro
(compare to Figure 5C). Collectively, these data indicate all
depots examined (BATs and WATs) contain varying amounts
of adipocyte progenitors that arise from Myf5+ precursors.
Because Myf5+ precursors are thought to give rise only
to BAT, we asked whether the Myf5-lineage APCs residing
in WAT have a brown preadipocyte signature. Importantly,
YFP mRNA expression is only detectable in the YFP+ APC pop-
ulations, validating the sorting purity (Figures S4E and S7). Both
the YFP+ and YFPneg APCs purified from the iBAT of myf5-
cre;R26R-EYFP mice express the brown fat marker Zic1, while
only the YFP+ iBAT APC pool expresses prdm16 (Figure 5H).
Neither marker is detectable in the YFP+ APCs purified from
rWAT, indicating that the Myf5+ white APCs do not express
classic brown fat markers. Moreover, both the YFP+ and YFPneg
APCs purified from rWAT more highly express the white fat
markers HoxC8 and HoxC9, which express at low or undetect-
able levels, respectively, in the APCs purified from iBAT (Fig-
ure 5H). Thus,Myf5-lineage APCs residing inWAT have a distinct
gene signature and are not equivalent to BAT progenitors.
Prolonged Exposure to a b3-Adrenoreceptor Agonist
Does Not Selectively Target Myf5+ Adipocyte Lineages
We next considered the possibility that the Myf5-lineage in WAT
could be a source of a distinct population of brite fat cells
different from the Myf5neg brite fat cells residing in inguinal
WAT. It is reported for some strains that rWAT briefly expresses
UCP1 in early postnatal development andmight transiently func-
tion like classical brown fat, possibly regaining that function in
adult mice when stimulated (Xue et al., 2007). We compared
ucp1 expression at 1, 2, 3, and 7 weeks of age between the
rWAT, ingWAT, and pgWAT. There is indeed a small transient
increase in ucp1 expression in rWAT between 1 and 2 weeks
of age (2.1-fold) (Figure S5A); however, ingWAT transiently
increases ucp1 expression to a much higher degree (33.3-
fold). Thus, if rWAT transiently contributes to thermogenesis in
these mice, that contribution is likely overshadowed by the
ingWAT. To further test whether the Myf5-lineage adipocytes
in WAT are the inducible brown fat cells, we treated myf5-
cre;R26R-LacZmice for 1 week with CL316,243 (a b3-adrenore-
ceptor agonist) and examined the overlap between multilocular
cells and LacZ expression. Consistent with unstimulated
ingWAT (Figures 4E and S3C), none of the multilocular cells in
either ingWAT or pgWAT following prolonged CL316,243. Brown fat is marked with an arrow in control. In the mutant, iBAT (1), sBAT (2),
e seen forming prematurely in the mutants by E17.5 (arrow).
nd PTENmyf5cKO (black bars) (n = 8).
< 0.05, **p < 0.01, ***p < 0.001). See also Figure S2.
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Figure 3. PTENmyf5cKO Mice Completely Lack PTEN in WAT and BAT
(A) IHC and H&E stains on serial sections of E14.5 BAT precursor for PTEN and phospho-AktS473 in control and PTENmyf5cKO mice.
(B) PTEN, phospho-AktT308, and phospho-AktS473 levels in lysates from iBAT, iWAT, rWAT, triceps, and trapezius. See also Figure S3.
(C) Proliferation curve of primary BAT preadipocytes (n = 3; points represent mean ± SEM; t test; *p < 0.05, **p < 0.01).
(D) Primary BAT preadipocytes were differentiated and stained with oil red O at different stages.
(E) Tissue mRNA expression of PTEN (n = 5–6; bars represent mean ± SEM; t test; ***p < 0.001).
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CL316,243-induced multilocular cells in rWAT are LacZ positive
(Figure S5B), consistent with the high level of Myf5-lineage
tracing to this depot. Both ingWAT and rWAT strongly induce
ucp1 expression relative to pgWAT upon CL316,243 treatment
(Figure S5C). Thus, b3-adrenoreceptor stimulation induces brite
adipocytes arising from both Myf5+ and Myf5neg lineages.354 Cell Metabolism 16, 348–362, September 5, 2012 ª2012 ElsevieNext, we asked if prolonged exposure to CL316,243 selec-
tively stimulates expansion of Myf5-lineage APCs. In myf5-cre;
R26R-EYFP mice, CL316,243 has little effect on YFP+ APC
composition in BAT, which is not surprising because brown
adipocytes are already present and fully differentiated in clas-
sical BAT depots (Figure 6A). Interestingly, CL316,243 increases
the percentage of YFPneg APCs in the iWAT (Figure 6A), as wellr Inc.
Figure 4. A Subset of White Adipocytes Trace to the Myf5 Lineage
(A–C) YFP (A), Ucp1 (B), and Prdm16 (C) mRNA expression in tissues (n = 5) prepared from myf5-cre;R26R-YFP mice (Tri, triceps; Q, quadriceps; G, gastroc-
nemius; H, heart; L, liver; S, spleen; K, kidney). In (A), YFP level detected in each tissue from mice lacking Cre was subtracted. Bars represent mean ± SEM.
(D) Images of the indicated depots from a R26R-LacZ and a myf5-cre;R26R-LacZ mouse after X-gal staining.
(E) b-galactosidase activity in tissues from negative control (R26R-LacZ) and from myf5-cre;R26R-LacZ or PTENmyf5cKO-LacZ mice. Counterstained with NFR.
Liver and spleen at 403; others at 633. See also Figure S3.
(F and G) qRT-PCR analysis of Cidea, Prdm16, Zic1,Ucp1,HoxC8,HoxC9, and DPT in whole iBAT and rWAT (n = 8; horizontal line indicates the mean; *p < 0.05,
**p < 0.01).
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Figure 5. The Number of Myf5 Lineage-Derived Adipocyte Progenitor Cells in Each Depot Varies with Its Anatomical Location
(A) Macroscopic (top) and microscopic (403, bottom) images of SVF cultures from R26R-LacZ and myf5-cre;R26R-LacZ mice from the indicated depots and
stained with X-gal.
(B) Positive and negative b-gal cell quantification shown in (A).
(C) Positive and negative b-gal activity in only the individual lipid containing cells (see Figure S4A).
(D) Macroscopic (top) and microscopic (403, bottom) images of SVF cultures from PTENmyf5cKO and PTENmyf5cKO-LacZ mice stained with X-gal.
(E) Positive and negative b-gal cell quantification shown in (D).
(F) Positive and negative b-gal activity in only the individual lipid-containing cells (see Figure S4B).
(G) APCs were purified from the myf5-cre;R26R-YFP (wild-type) fat depots. Yellow bars, YFP+ APCs; white bars, YFPneg (n = 9).
(H) qRT-PCR of Zic1, prdm16,HoxC8, andHoxC9mRNA in YFP+ and YFPneg APCs purified from the iBAT and rWAT (n = 3) ofmyf5-Cre;R26R-YFPmice. ND, not
detectable. Bars represent mean ± SEM; ***p < 0.001. See also Figure S4.
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effect on YFP+ APC composition in rWAT (Figure 6A). CL316,243
also has little effect on the overall APC composition of ingWAT or
pgWAT (Figure 6A), although the total number of YFPneg and
YFP+ APCs in these depots increases (Figure S5D). Thus,
CL316,243 does not selectively stimulate expansion of the
APCs arising from Myf5+ precursors.
Deleting PTEN withmyf5-cre Selectively Expands
Adipocyte Lineages Arising from Myf5+ Precursors
Lineage tracing clearly indicates that iWAT and rWAT contain
a mixture of APCs arising from both Myf5+ and Myf5neg pre-
cursors; however, sizing individual iWAT and rWAT adipocytes356 Cell Metabolism 16, 348–362, September 5, 2012 ª2012 Elseviein the PTENmyf5cKO mice does not partition them into two
distinct populations (Figure 2C). Moreover, immunoblotting and
RT-PCR analysis show that myf5-cre completely deletes
PTEN in iWAT and rWAT (Figures 3B and 3E). This contradicts
the lineage tracing data showing that the Myf5-lineage
partially contributes to the adipocyte population in these
depots and therefore predicts only partial PTEN deletion (Fig-
ure 5G). To begin unraveling the mechanism by which PTEN
loss in Myf5+ precursors redistributes body fat, resulting in
depots completely lacking PTEN, we first examined the Myf5
lineage in myf5-cre;PTENfl/fl;R26R-LacZ (PTENmyf5cKO-LacZ)
mice. The PTENmyf5cKO-LacZ mice show strong uniform b-galac-
tosidase staining in the iBAT, sBAT, iWAT, and rWAT depotsr Inc.
Figure 6. Deleting PTEN with myf5-cre, but Not Prolonged CL316,243 Treatment, Selectively Expands the Myf5+ Adipocyte Lineages
(A) APCs were purified from myf5-cre;R26R-YFP mice treated with PBS or CL316,243 for a week (n = 3). Yellow bars, YFP+ APCs; white bars, YFPneg.
(B) APCs were purified by FACS from the PTENmyf5cKO-YFP fat depots (n = 4). Yellow bars represent YFP+ APCs; white bars are YFPneg.
(C) Total number of YFP+ (yellow bars, top) and YFPneg cells (white bars, bottom) in each depot of myf5-cre;R26R-YFP and PTENmyf5cKO-YFP (cKO) mice (n = 4).
(D) qRT-PCR of Zic1 and prdm16mRNA in YFP+ and YFPneg APCs purified from the iBAT and rWAT (n = 3) of PTENmyf5cKO-YFPmice. ND indicates not detectable.
(E) qRT-PCR of HoxC8 and HoxC9 mRNA as in (D). Bars represent mean ± SEM; t test; *p < 0.05, **p < 0.01, ***p < 0.001. See also Figure S5.
Cell Metabolism
The Myf5 Lineage Composition of Adipose Tissuecompared to controls (Figure 4E). Most SVF cells (>95%) purified
from PTENmyf5cKO-LacZ iBAT, iWAT, and rWAT stain positive for
LacZ compared to 0% in control cells that lack the reporter
(Figures 5D and 5E). After inducing differentiation, almost all of
the lipid-containing cells derived from iWAT (97.9%) and rWAT
(99.1%) stain positive for LacZ (Figures 5F and S4B), indicating
that most PTENmyf5cKO-LacZ white adipocyte progenitors and
mature adipocytes arise from Myf5+ precursors.
Next we generated myf5-cre;PTENfl/fl;R26R-EYFP
(PTENmyf5cKO-YFP) mice to ask how deleting PTEN affects the
Myf5 lineage contribution to the APC pools in each depot.
Importantly, PTEN mRNA is barely detectable in the YFP+
APCs isolated from PTENmyf5cKO-YFP mice, confirming high
deletion efficiency (Figure S5E). PTEN-deficient YFP+ APCs are
also larger than control YFP+ APCs, consistent with PTEN regu-
lating cell size (Figure S5F). A slight increase in the percentage of
YFP+ APCs residing in BAT is detectable in PTENmyf5cKO-YFP
mice (up from 90% to 95%) (Figure 6B). Most importantly,
compared to the Myf5 lineage contribution to the APC pools
in PTEN positive mice (Figure 5G), the percentage of YFP+
APCs residing in iWAT and rWAT in PTENmyf5cKO-YFP miceCell Meincreases to 91% and 89%, respectively (Figure 6B). Thus,
deleting PTEN with myf5-cre increases the Myf5-lineage contri-
bution to the APC pool in iWAT and rWAT to levels comparable
with BAT.
Consistent with PTENmyf5cKOwhole fat pads having more total
cells (Figures 2D–2G), the total number of YFP+ APCs residing in
each PTENmyf5cKO-YFP fat depot also increases (Figure 6C). To
confirm that PTEN-deficient APCs have the same adipogenic
potential as PTEN positive control APCs, we performed adipo-
genic colony forming assays. Single Myf5-lineage APCs from
control and PTEN-deficient BATs or WATs were sorted, clonally
expanded, and differentiated (see Supplemental Experimental
Procedures). After induction, more than 79% of the BAT and
73% of the WAT APC colonies contained cells staining positive
for neutral lipids (Figures S5G and S5H). These results are
consistent with recent reports (Joe et al., 2010; Lee et al.,
2012). Adipogenic colony forming potential is as efficient if not
higher when PTEN is deleted (86.16% for BAT and 79.49% for
WAT) (Figures S5G and S5H), indicating that hyperplasia of
PTENmyf5cKO fats probably results from increased numbers of
adipocyte progenitors.tabolism 16, 348–362, September 5, 2012 ª2012 Elsevier Inc. 357
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markers cidea, prdm16, zic1, and ucp1 remain highly expressed
in PTENmyf5cKO whole iBAT compared to rWAT, with PTEN dele-
tion causing only a negligible drop in cidea and ucp1 expression
in the iBAT (Figure 4F, PTENmyf5cKO). This indicates that PTEN
loss does not affect BAT marker gene expression. Similarly,
PTEN loss does not affect Hoxc8 and Dpt expression in
rWAT, while Hoxc9 expression is slightly reduced (Figure 4G,
PTENmyf5cKO). Thus, white fat identity is also largely unperturbed
by PTEN loss. Finally, we profiled the molecular identity of the
YFP+ and YFPneg APCs purified from the PTENmyf5cKO-YFP iBAT
and rWAT depots. Similar to wild-type YFP+ APCs (Figures 5G
and 5H), the PTEN-deficient BAT APCs express Zic1 and
Prdm16, which are undetectable in PTENmyf5cKO-YFP rWAT
APCs (Figure 6D). Moreover, the white fat markers Hoxc8 and
Hoxc9 express at low or undetectable levels, respectively, in
PTENmyf5cKO-YFP iBAT APCs, but continue to express highly in
PTENmyf5cKO-YFP rWAT APCs (Figure 6E). We conclude that
deleting PTEN with myf5-cre does not affect APC identity or
adipogenic colony forming potential, but expands the Myf5
adipocyte lineages such that all fat depots (brown and white)
in PTENmyf5cKO mice are exclusively derived from Myf5+
precursors.
DISCUSSION
Little is known about the developmental origins of adipose
tissue, what controls adipose tissue heterogeneity, and what
determines the variable body fat distribution patterns seen in
humans. Understanding this is clinically important because
some fats (e.g., brown fat and subcutaneous white fat) show
favorable metabolic characteristics, while other fats (e.g.,
visceral white fat) are linked to metabolic disorders. Moreover,
some partial lipodystrophies, which in general are poorly under-
stood, often manifest as adipose tissue distribution disorders.
In this study we made the surprising finding that a subset of
unilocular white adipocytes are derived from a precursor cell
that expresses themyf5-cre knockin allele and that the contribu-
tion of this lineage to each adipose tissue varies with depot
location.
Different fat depots develop at different stages of postnatal
life and have unique characteristics (reviewed in Billon and
Dani, 2012; Gesta et al., 2007). This has led to the hypothesis
that different white adipose depots originate from distinct meso-
dermal locations. However, a specific mesoderm-derived white
adipose lineage had not been described. Our discovery that
a subset of unilocular white adipocytes originates from Myf5-
Cre+ precursors supports this hypothesis and identifies at least
oneWAT lineage arising from the mesoderm. There is also accu-
mulating evidence that the adipocyte population within certain
depots is heterogeneous (Blu¨her et al., 2002; Fortier et al.,
2005). Moreover, two distinct subtypes of preadipocytes have
been characterized in human fat, the proportions of which vary
among depot location (Tchkonia et al., 2005). Our finding that
WAT contains amixed population of Myf5-Cre+ andMyf5-Creneg
derived progenitors supports this.
We do not yet know if being of Myf5+ or Myf5neg origin has
metabolic significance or if the Myf5 lineage contribution to
each depot varies with strain background. Differences in these358 Cell Metabolism 16, 348–362, September 5, 2012 ª2012 Elseviecharacteristics could affect body fat pattering or sensitivity to
obesity. It is alternatively possible that despite distinct origins,
Myf5+ and Myf5neg adipocytes are functionally identical. This
would argue that while myf5-cre expression distinguishes the
origins of adipocytes, it should not be used to delineate them
functionally. Regardless, mutations affecting distinct develop-
mental lineages could be the pathological basis of some human
fat disorders (discussed below). Human adipose-derived stem
cells (ASCs) are abundantly available and obtainable by mini-
mally invasive procedures. Thus, understanding adipocyte
lineage variations could have important therapeutic implications
(reviewed in Tran and Kahn, 2010). For example, there may be
favorable characteristics associated with a particular develop-
mental origin, and selecting for the optimum ASC population
could offer distinct advantages.
Previous work using the same Myf5-cre knockin line sug-
gested that classical brown fat adipocytes, but not the inducible
brite fat cells, arise from Myf5+ precursors, leading to a widely
accepted model in which brown fat and skeletal muscle share
a common precursor (Seale et al., 2008, 2009) (reviewed in Billon
and Dani, 2012; Cristancho and Lazar, 2011; Fru¨hbeck et al.,
2009; Kajimura et al., 2010; Tseng et al., 2010). It is hypothesized
that the common origin of brown adipocytes and muscle
explains the favorable metabolic properties of brown fat. All
white adipocytes and brite adipocytes are thought to arise
from a unique undefined Myf5neg mesenchymal lineage(s). Our
Myf5-Cre lineage tracing studies are consistent with brown
adipocytes largely originating from a Myf5+ precursor. However,
our work further suggests that white fat depots contain a mixture
of adipocytes and resident APCs derived from both Myf5+ and
Myf5neg lineages, with the Myf5+ lineage being more highly
represented in some fats (e.g., iWAT and rWAT) compared to
others (e.g., ingWAT and pgWAT). We also find that the brite
adipocytes in the inguinalWAT do not label withMyf5-Cre, which
is also consistent with previous work. Although the same Myf5-
Cre knockin line is used in this study and in Seale et al., the
PTEN-deletion phenotype described here led us to examine
other white fat depots in addition to the largely Myf5neg inguinal
and perigonadal WATs examined by Seale et al. The only
discrepancy is that Seale et al. used indirect immunofluores-
cence to show that the interscapular WAT depot is YFP negative
(Seale et al., 2008). We also cannot detect YFP signal by indirect
immunofluorescence in interscapular WAT (or any other WAT)
using this approach, likely reflecting a technical limitation.
However, we additionally employed the ROSA26-LacZ reporter,
RT-PCR, and FACS analysis to clearly show Myf5-Cre lineage
tracing to the interscapular WAT. Based on these insights, which
were uncovered by deleting PTEN with Myf5-Cre and confirmed
through lineage tracing, we suggest an alternative model of
adipose tissue development (Figure 7).
We also considered the possibility that the Myf5-Cre marked
adipocytes in the iWAT and rWAT could represent an inducible
brown adipocyte-like lineage distinct from the Myf5neg brite
fat cells in the inguinal WAT. However, in both the iWAT
and rWAT, only a subset of the adipocytes arising from Myf5-
Cre+ precursors become multilocular following prolonged
CL316,243 treatment. We have adopted the perspective for
now that the developmental origins of brown, brite, and at
least a subset of white adipocytes cannot be delineated simplyr Inc.
Figure 7. Model of Adipose Tissue Development Based on Lineage Analysis and Conditional PTEN Deletion with Myf5-Cre
(A) Myf5-expressing progenitor cells give rise to a classical brown adipocytes as well as a subset of white adipocytes in iWAT and rWAT. Alternatively, Myf5-Cre-
expressing progenitor cells, distinct from those that give rise to classical BAT, could give rise to adipocytes in iWAT and rWAT, indicated by the question mark.
(B) Myf5neg progenitors of unknown origin give rise to ingWAT and pgWAT.
(C) Many adipose depots contain a mixed population of adipocyte progenitor cells arising from both Myf5-Cre+ and Myf5-Creneg precursors. The Myf5-lineage
significantly contributes to the adipocyte population in iWAT and rWAT, while in ingWAT and pgWAT the significance of the resident Myf5+ cells is unknown.
Notably, the multilocular ‘‘brite’’ fat cells residing in ingWAT at ambient temperature, or induced after prolonged exposure to CL316,243 (not shown in figure), do
not trace to the Myf5-Cre lineage.
(D) PTEN loss in Myf5+ precursors expands the Myf5+ preadipocyte pool.
(E) Upon differentiation, the PTEN-deficient adipocyte lineages accumulate excess lipid, resulting in overgrowth.
(F) The growingMyf5+ adipocyte lineages restrict development of Myf5neg adipocyte lineages, resulting in the selective expansion of fats exclusively derived from
Myf5+ precursors.
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within and between depots, particularly with respect to ucp1
expression dynamics, leads us to conclude that the iWAT,
rWAT, ingWAT, and pgWAT depots should be considered as
distinct types of white fat.
Recent studies of intramuscular adipose tissue find that these
particular adipocytes also do not originate from a Myf5-Cre ex-
pressing precursor (Joe et al., 2010; Liu et al., 2012; Schulz
et al., 2011). Notably, the study by Liu et al. finds that Pax3-
Cre+ precursors, like Myf5-Cre+ precursors, give rise to brown
fat and, importantly for our study, roughly half of the adipocytes
in the iWAT (Liu et al., 2012). However, it is also possible that
Pax3-Cre and Myf5-Cre could be transiently and independently
expressed in distinct precursor pools, different from those that
give rise to skeletal muscle or to brown fat. This requires further
investigation. We currently favor the idea that Myf5-expressing
precursors may be more akin to the multipotential Engrailed-1-
expressing precursors in the central dermomyotome, which
are reported to become BAT, skeletal muscle, and dermis (Atit
et al., 2006).
Insulin through PI3K regulates adipogenesis in both brown
and white fat (Cannon and Nedergaard, 2004; Rosen and
MacDougald, 2006). Therefore, it is perhaps not surprising
that deleting PTEN with Myf5-Cre increases the lipid content of
both brown and white adipocytes. However, a previous study
targeting PTEN deletion to adipocytes with the aP2-Cre did not
detect any changes in adipose tissue mass or in lipid droplet
size (Kurlawalla-Martinez et al., 2005). Thus, for reasons unclear,
it appears that increasing PI3K signaling in brown or white prea-
dipocytes can cause excessive lipid accumulation, but once
an adipocyte fully differentiates, the ability to further increase
lipid content through PI3K activation is lost. That PTEN regulates
brown fat is supported by a recent paper describing a transgenic
mouse model of PTEN, in which PTEN is overexpressed in all
tissues (Ortega-Molina et al., 2012). Although systemic effects
cannot be separated from tissue-specific effects in this model,
PTEN-overexpressing mice have reduced lipid content in their
interscapular brown fat pads. Interestingly, globally overex-
pressing PTEN appears to increase BAT activity as well as
increase the number of multilocular adipocytes in inguinal
WAT, leading the authors to conclude that PTEN positively
regulates energy expenditure, although the possibility that over-
expressing PTEN also suppresses adipogenesis is not con-
sidered. Exactly how overexpressing PTEN increases energy
expenditure and its physiological significance to normal regu-
lation of thermogenesis remain unclear.
The fact that deleting PTEN with Myf5-Cre redistributes body
fat raises the interesting possibility that variations in metabolic
regulation between distinct adipocyte lineages could be a factor
in controlling body fat distribution. For example, if a particular
lineage is more insulin sensitive, that lineage may preferentially
expand. Although PTEN loss affects many downstream path-
ways, the PTENmyf5cKO mice have low circulating glucose levels
and are highly glucose tolerant and insulin sensitive, suggesting
they are hypersensitive to insulin (J.S.-G. and D.A.G., unpub-
lished data). Thus, one factor contributing to the selective ex-
pansion of PTEN-deficient fats may be that adipocytes lacking
PTEN preferentially clear and store glucose (as lipid), leaving
no excess circulating energy available for storage in the Myf5neg360 Cell Metabolism 16, 348–362, September 5, 2012 ª2012 Elsevieadipocyte lineages. In this model, the Myf5neg lineages would
never receive the adipogenic signals to differentiate. Although
PTEN deletion is a genetically engineered and extreme example
of insulin/PI3K pathway activation, more subtle and natural
variations in metabolic regulation between distinct lineages
could partly explain the variable body fat patterning seen in
humans.
Interestingly, thePTENmyf5cKO phenotype is remarkably similar
to a mysterious human disorder called Multiple Symmetric
Lipomatosis (MSL) (also called Benign Symmetric Lipomatosis
or Madelung’s disease) (Herbst, 2012). MSL is characterized
by adipose tissue overgrowth in the upper back, neck, and
shoulders and is often accompanied by decreased visceral
adiposity and muscle atrophy. Patients suffer from disfiguration
and neuropathy and are at risk for sudden death (Enzi et al.,
2002; Guastella et al., 2002; Ramos et al., 2010). Although poorly
characterized, the location, histological features, and metabolic
properties of the diseased fat led to the proposal that MSL may
be of brown fat origin (Cinti et al., 1983; Nisoli et al., 2002;
Zancanaro et al., 1990). Here we describe a model of partial
lipodystrophy and suggest one possible explanation for the
pathology associated with this condition is that a certain adipo-
cyte lineage analogous to the Myf5 lineage may be selectively
targeted, resulting in altered body fat distribution.
In this report, we provide evidence that Myf5+ precursors
give rise to both brown and white adipocytes and show that
activating PI3K signaling in the Myf5+ lineage redistributes
body fat. Future studies aimed at defining the significance of
adipocyte ancestry and the lineage composition of different fat
depots and to understanding how genetic variation or mutations
affect distinct adipocyte precursor pools will significantly impact
the understanding and treatment of common (e.g., obesity,
metabolic syndrome, diabetes) and rare (e.g., lipomatosis, lipo-
dystrophy) human diseases of adipose tissue imbalance.
EXPERIMENTAL PROCEDURES
Materials
PTEN, S473-Akt, T308-Akt, and pan-Akt antibodies were from Cell Signal-
ing Technologies. 7AAD was from BD Biosciences, calcein blue was from
Invitrogen, and CD29-Biotin, Streptavidin-PE-Cy7, CD31-PE, CD45-PE,
Ter119-PE, CD34-Alexa700, and Sca1-APC were all from eBiosciences.
CL316243 was from Tocris. All other reagents were from Sigma-Aldrich.
Mice
PTEN floxedmice (Jackson Laboratories) were crossed tomice expressing the
Cre recombinase transgene from the Myf5 promoter (Myf5-CRE) (Tallquist
et al., 2000). Rosa26-LSL-YFP and Rosa26–LSL-LacZ were from Jackson
Laboratories. Mice were kept on a daily 12 hr light/dark cycle and fed a normal
chow diet (Prolab Isopro RMH 3000) from LabDiet ad libitum. All animal exper-
iments were approved by the University of Massachusetts Medical school
animal care and use committee.
Tissue Harvest
Adipose tissue depots described in Walde´n et al., 2012 were carefully
dissected to avoid contamination from surrounding tissue. Interscapular
WAT refers to the tissues named bsWAT and asWAT in Walde´n et al., 2012.
Gene Expression Analysis
Total RNA was isolated from cells or tissues using QIAzol (Invitrogen) and
RNeasy kit (Invitrogen). Equal amounts of RNA were retro-transcribed to
cDNA using High-Capacity cDNA Reverse Transcription Kit (#4368813,r Inc.
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The Myf5 Lineage Composition of Adipose TissueApplied Biosystems). qRT-PCR was run in 10 ml reactions in a StepOnePlus
real-time PCR system machine from Applied Biosystems using SYBR Green
PCR master mix (#4309156, Applied Biosystems) according to manufacturer
instructions. Standard and melting curves were run in every plate for every
gene to ensure efficiency and specificity of the reaction. Primer sequences
are listed in the Supplemental Experimental Procedures (Table S2).
Histology and Image Analysis
ImageJ (NIH) was used to calculate cell area, diameter, and nuclei number
in formalin-fixed tissues sectioned at 5 mm of thickness. Embedding and
sectioning was done by the UMass Morphology Core.
Primary Cell Isolation and FACS Analysis
Primary brown preadipocytes were isolated and immortalized according to
Fasshauer et al., 2001. SVF from all adipose depots were isolated using
the same protocol. Adipose precursor cells (APCs) were isolated from SVF
according to previously established markers (Rodeheffer et al., 2008; Tang
et al., 2008) using a FACS Aria II cell sorter equipped with FASCDiva software
in the UMass Flow Cytometry Core Facility.
Adipogenic Colony Formation Assay
Single cell colony formation assay was done as previously reported (Lee
et al., 2012) with minor modifications. See also Supplemental Experimental
Procedures.
LacZ Staining
LacZ staining was done as in Tang et al., 2008 with minor modifications. See
also Supplemental Experimental Procedures.
Statistical Analysis
Unless otherwise stated, data are presented as the mean ± SEM. A t test
was used to determine statistical significance: * < 0.05; ** < 0.01; *** < 0.001.
See also Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, two tables, and Supple-
mental Experimental Procedures and can be found with this article online at
http://dx.doi.org/10.1016/j.cmet.2012.08.003.
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